The Role of Lazertinib in Patients With EGFR-Variant Non-Small Cell Lung Cancer

被引：0
|
作者：
Cheng, Haiying [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Montefiore Einstein Comprehens Canc Ctr, Dept Med Oncol, 1695 Eastchester Rd,2nd Floor, New York, NY 10461 USA
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 10期
关键词：
D O I：
10.1001/jamaoncol.2024.2607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1352 / 1353
页数：2
相关论文
共 50 条
  • [31] EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
    Park, Sehhoon
    Ku, Bo Mi
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Lee, Se-Hoon
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1288 - 1290
  • [32] EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
    Reade, Chad A.
    Ganti, Apar Kishor
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 215 - 224
  • [33] EGFR-Variant Adenoid Cystic Carcinoma of the Lung
    Mendes, Maria Aurora
    Barroso, Ana
    Campainha, Sergio
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : E178 - E181
  • [34] Comparison of EGFR FISH and EGFR SISH in non-small cell lung cancer
    Wulf, M.
    Behnke, S.
    Soltermann, A.
    Tischler, V
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 153 - 153
  • [35] Lazertinib-Induced Rhabdomyolysis in a Patient With Non-Small Cell Lung Cancer: A Case Report
    Lee, Seunghun
    Choi, Juwhan
    Lee, Sung Yong
    RESPIROLOGY CASE REPORTS, 2025, 13 (02):
  • [36] Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant A Randomized Clinical Trial
    Fang, Wenfeng
    Zhao, Yuanyuan
    Luo, Yongzhong
    Yang, Runxiang
    Huang, Yan
    He, Zhiyong
    Zhao, Hui
    Li, Mingjun
    Li, Kai
    Song, Qibing
    Du, Xiaobo
    Sun, Yulan
    Li, Wei
    Xu, Fei
    Wang, Zhiyu
    Yang, Kunning
    Fan, Yun
    Liu, Baogang
    Zhao, Hongyun
    Hu, Ying
    Jia, Li
    Xu, Shen
    Yi, Tienan
    Lv, Dongqing
    Lan, Haitao
    Li, Mengxia
    Liang, Wenhua
    Wang, Yongsheng
    Yang, Hui
    Jia, Yuming
    Chen, Yuan
    Lu, Junguo
    Feng, Jifeng
    Liu, Chunling
    Zhou, Ming
    Zhou, Jianya
    Liu, Xianling
    Zhou, Ningning
    He, Ming
    Dong, Xiaorong
    Chen, Hualin
    Chen, Yongxing
    Su, Haichuan
    Li, Xiaoling
    Zhang, Zhihong
    Yang, Lei
    Cheng, Ying
    Chen, Likun
    Hou, Xue
    Zhang, Yu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (07): : 561 - 570
  • [37] Use of the Idylla EGFR Mutation Test for Variant Detection in Non-Small Cell Lung Cancer Samples
    Hawkins, Paul
    Stevenson, Tracey
    Powari, Manish
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (04) : 653 - 660
  • [38] Evaluation of the role of variant allele frequency in EGFR mutated non-small cell lung cancer treated with first line osimertinib
    Brambilla, M.
    Lorenzini, D.
    Occhipinti, M.
    Manglaviti, S.
    Beninato, T.
    Mazzeo, L.
    Agnelli, L.
    Leporati, R.
    Zanella, C.
    Leone, A. G.
    Fotia, G.
    Prelaj, A.
    Lo Russo, G.
    Grande, I.
    Tamborini, E.
    Perrone, F.
    Ganzinelli, M.
    Pruneri, G.
    De Braud, F. G. M.
    Proto, C.
    ANNALS OF ONCOLOGY, 2023, 34
  • [39] EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non-Small Cell Lung Cancer Patients
    Yam, Irene
    Lam, David Chi-Leung
    Chan, Kaimin
    Ho, James Chung-Man
    Ip, Mary
    Lam, Wah-Kit
    Chan, Tai-Kwong
    Chan, Vivian
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1131 - 1140
  • [40] THE ROLE OF RADIOGENOMICS IN EGFR AND KRAS MUTATION STATUS PREDICTION AMONG NON-SMALL CELL LUNG CANCER PATIENTS
    Freitas, C.
    Pereira, T.
    Pinheiro, G.
    Dias, C.
    Hespanhol, V.
    Costa, J. L.
    Cunha, A.
    Oliveira, H.
    CHEST, 2020, 157 (06) : 16A - 16A
12345